X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (442) 442
humans (406) 406
bcr-abl1 (385) 385
hematology (287) 287
chronic myeloid leukemia (274) 274
oncology (250) 250
imatinib (214) 214
chronic myelogenous leukemia (201) 201
fusion proteins, bcr-abl - genetics (177) 177
leukemia (168) 168
leukemia, myelogenous, chronic, bcr-abl positive - genetics (158) 158
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (154) 154
male (149) 149
chronic myeloid-leukemia (148) 148
hemic and lymphatic diseases (146) 146
female (142) 142
cml (126) 126
adult (125) 125
middle aged (120) 120
tyrosine kinase inhibitors (117) 117
bcr-abl (114) 114
protein kinase inhibitors - therapeutic use (112) 112
imatinib mesylate (101) 101
tyrosine (96) 96
aged (94) 94
cancer (92) 92
abl1 (90) 90
analysis (87) 87
dasatinib (85) 85
mutation (85) 85
antineoplastic agents - therapeutic use (81) 81
genetic aspects (78) 78
philadelphia chromosome (78) 78
prognosis (70) 70
nilotinib (69) 69
adolescent (65) 65
tyrosine kinase inhibitor (65) 65
follow-up (64) 64
pyrimidines - therapeutic use (64) 64
treatment outcome (64) 64
young adult (63) 63
leukemia, myelogenous, chronic, bcr-abl positive - pathology (62) 62
animals (61) 61
bcr‐abl1 (60) 60
research (58) 58
care and treatment (57) 57
minimal residual disease (57) 57
fusion proteins, bcr-abl - metabolism (56) 56
chronic myeloid leukaemia (55) 55
therapy (55) 55
philadelphia-chromosome (52) 52
hematology, oncology and palliative medicine (51) 51
resistance (51) 51
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (50) 50
piperazines - therapeutic use (49) 49
acute lymphoblastic-leukemia (47) 47
kinases (47) 47
polymerase chain reaction (47) 47
tyrosine kinase (47) 47
aged, 80 and over (45) 45
cell biology (44) 44
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (44) 44
precursor cell lymphoblastic leukemia-lymphoma - genetics (43) 43
myeloid leukemia (42) 42
patients (42) 42
protein-tyrosine kinase (42) 42
benzamides (40) 40
medicine & public health (40) 40
protein kinase inhibitors - pharmacology (40) 40
article (39) 39
bcr (39) 39
child (38) 38
chronic-phase (38) 38
acute lymphoblastic leukemia (37) 37
diagnosis (37) 37
expression (37) 37
pathology (37) 37
stem-cells (37) 37
drug resistance, neoplasm - genetics (36) 36
genes (36) 36
genetics & heredity (36) 36
mice (36) 36
recommendations (35) 35
stem cells (35) 35
bcr-abl1 transcript levels (34) 34
fusion proteins, bcr-abl - antagonists & inhibitors (34) 34
polymerase-chain-reaction (34) 34
proteins (34) 34
chromosomes (33) 33
gene expression (33) 33
survival (33) 33
acute lymphocytic leukemia (32) 32
antineoplastic agents (32) 32
early molecular response (32) 32
bcr/abl1 (31) 31
molecular response (31) 31
gene (30) 30
abridged index medicus (29) 29
blast crisis (29) 29
cell line, tumor (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (698) 698
French (10) 10
Polish (4) 4
Czech (3) 3
German (3) 3
Korean (3) 3
Spanish (3) 3
Slovenian (2) 2
Chinese (1) 1
Hungarian (1) 1
Japanese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 08/2019, Volume 9, p. 764
In Chronic Myeloid Leukemia (CML), successful treatment requires accurate molecular monitoring to evaluate disease response and provide timely interventions... 
CHRONIC PHASE | BCR-ABL1/ABL1(IS) | Chronic Myeloid Leukemia | halving-time | CHRONIC MYELOID-LEUKEMIA | CESSATION | tyrosine kinase inhibitors | ONCOLOGY | RECOMMENDATIONS | CLINICAL-APPLICATIONS | IMATINIB | DYNAMICS | MOLECULAR RESPONSE | MUTATIONS | EXPRESSION | doubling-time | Genetic aspects | Messenger RNA | Research | Chronic myeloid leukemia | Drug therapy | BCR-ABL1/ABL1IS
Journal Article
Cancer research, ISSN 0008-5472, 12/2018, Volume 78, Issue 23, pp. 6539 - 6548
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an inherited cancer syndrome associated with a highly aggressive form of type 2 papillary renal... 
HLRCC | ABL1 | q-oxPTPome | Oxidation | PTPN12
Journal Article
Virchows Archiv, ISSN 0945-6317, 9/2015, Volume 467, Issue 3, pp. 357 - 363
Journal Article
Journal Article
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S66 - S70
Journal Article
Journal Article
Journal of Pediatric Hematology/Oncology, ISSN 1077-4114, 08/2018, Volume 40, Issue 6, pp. e397 - e399
Fluorescent in situ hybridization (FISH) analysis is the standard methods for screening ABL1 fusions, which is recurrently translocated in pediatric acute... 
FISH | NUP214-ABL1 | ABL1 class fusions | BCP-ALL | ONCOLOGY | PROGRESS | ABL1 | PEDIATRICS | PATIENT | AMPLIFIED EPISOMES | HEMATOLOGY | REMISSION
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 09/2019, Volume 9
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2014, Volume 4, p. 54
The t(9;22)(q34;q11) or Philadelphia chromosome creates a BCR-ABL1 fusion gene encoding for a chimeric BCR-ABL1 protein. It is present in 3-4% of pediatric... 
Chemotherapy | Acute lymphoblastic leukemia | Tyrosine kinase inhibition | BCR-ABL1 | Hematopoietic stem-cell transplantation | Hematopoietic Stem Cell Transplantation | Tyrosine Kinase Inhibition | chemotherapy | Acute Lymphoblastic Leukemia
Journal Article